arsenic trioxide has been researched along with Familial Nonmedullary Thyroid Cancer in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Au, WY; Fong, BM; Lang, BH; Mao, KJ; Tam, S | 1 |
| Firkin, F | 1 |
2 other study(ies) available for arsenic trioxide and Familial Nonmedullary Thyroid Cancer
| Article | Year |
|---|---|
Thyroid arsenic content and papillary thyroid carcinoma arising 10 years after oral arsenic trioxide therapy for refractory acute promyelocytic leukemia.
Topics: Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Carcinoma; Carcinoma, Papillary; Female; Humans; Leukemia, Promyelocytic, Acute; Neoplasms, Second Primary; Oxides; Thyroid Cancer, Papillary; Thyroid Gland; Thyroid Neoplasms; Young Adult | 2014 |
Carcinogenic risk of retained arsenic after successful treatment of acute promyelocytic leukemia with arsenic trioxide: a cause for concern?
Topics: Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Carcinoma; Carcinoma, Papillary; Female; Humans; Leukemia, Promyelocytic, Acute; Neoplasms, Second Primary; Oxides; Thyroid Cancer, Papillary; Thyroid Neoplasms | 2014 |